Search for: "Dr. Reddy" Results 321 - 340 of 395
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jan 2009, 6:11 am
Reuters notes: Under the settlement, GeoPharma can commercially launch its generic product, with 6 months marketing co-exclusivity, on July 1, 2012, or earlier in certain circumstances.See alsohttp://ipbiz.blogspot.com/2008/12/dr-reddys-settles-with-schering-over.html [Under the settlement, India-based Dr. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
24 Dec 2008, 3:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Classen v Biogen (not precedential): Federal Circuit applies Bilski to the life sciences (Holman's Biotech IP Blog) (Inventive Step) (Hal Wegner) (EFF) (Patently-O) (Patent Prospector) (The Fire of Genius) (Patent Baristas) (Managing Intellectual Property) (Patent Docs) (Spicy IP)   General India: Investing farmers with IP… [read post]
5 Dec 2008, 1:00 pm
FDA issues draft guidance on submission of patent information for certain old antibiotics (FDA Law Blog) US: FDA publishes new guidance on contents of a complete submission for the evaluation of proprietary names (FDA Law Blog) USPTO appeals Wyeth v Dudas decision on patent term adjustment calculation; more patentees (including Molecular Insight and Biogen) follow Wyeth’s lead in seeking additional patent term adjustment (IP Updates) (Patent Docs) (Law360) (Patent Docs) (Law360) (Law360)… [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
15 Oct 2008, 9:43 am
High Court (Commercial Cout) Office of Fair Trading v Abbey National Plc & Ors [2008] EWHC 2325 (Comm) (08 October 2008) High Court (Patents Court) Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Company Ltd [2008] EWHC 2345 (Pat) (13 October 2008) Source: www.bailii.org        [read post]
13 Oct 2008, 2:41 pm
Hot off the press comes the ruling today of Mr Justice Floyd (Patents Court, England and Wales) in Dr Reddy's Laboratories (UK) Ltd v Eli Lilly and Company Ltd [2008] EWHC 2345 (Pat). [read post]
9 Oct 2008, 7:29 pm
  Dr Reddy’s R&D IP team members GVS Sesha Kumar and Rakesh Mishra have just published a thought provoking piece in Managing IP magazine (How pharma companies can leverage their IP rights). [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
11 Aug 2008, 4:08 am
A patent at issue in the case involved polymorphs. [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]